The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
Open accessAbstract
Antibiotic-resistant bacterial infections arising from acquired resistance and/or through biofilm formation necessitate the development of innovative ‘outside of the box’ therapeutics. Nanomaterial-based therapies are promising tools to combat bacterial infections that are difficult to treat, featuring the capacity to evade existing mechanisms associated with acquired drug resistance. In addition, the unique size and physical properties of nanomaterials give them the capability to target biofilms, overcoming recalcitrant infections. In this Review, we highlight the general mechanisms by which nanomaterials can be used to target bacterial infections associated with acquired antibiotic resistance and biofilms. We emphasize design elements and properties of nanomaterials that can be engineered to enhance potency. Lastly, we present recent progress and remaining challenges for widespread clinical implementation of nanomaterials as antimicrobial therapeutics. In this Review, Rotello and colleagues discuss the mechanisms by which nanomaterials can be used to target antibiotic-resistant bacterial infections, highlight design elements and properties of nanomaterials that can be engineered to enhance potency, and explore recent progress and remaining challenges for clinical implementation of nanomaterials as antimicrobial therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Cited by
Understanding bacterial biofilms: From definition to treatment strategies
Zhao, A., Sun, J., & Liu, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1137947 · Cited by 743
Synergistic antibacterial strategy based on photodynamic therapy: Progress and perspectives
Hu, X., Zhang, H., Wang, Y., Shiu, B.-C., Lin, J.-H., Zhang, S., Lou, C.-W., & Li, T.-T. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.138129 · Cited by 365
Tripathi, N., & Goshisht, M. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00014 · Cited by 320
Yagoub, A. E. A., Al-Shammari, G. M., Al-Harbi, L. N., Subash-Babu, P., Elsayim, R., Mohammed, M. A., Yahya, M. A., & Fattiny, S. Z. A. (2022) · Applied Sciences · doi:10.3390/app122211613 · Cited by 54
Yang, N., Yang, X., Cheng, S., Gao, X., Sun, S., Huang, X., Ge, J., Han, Z., Huang, C., Wang, Y., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.010 · Cited by 38
Metadata
- Authors
- Makabenta, J. M. V., Nabawy, A., Li, C.-H., Schmidt-Malan, S., Patel, R., & Rotello, V. M.
- Venue
- Nature Reviews Microbiology
- Published
- 2020-08-19
- Volume
- 19
- Issue
- 1
- Pages
- 23-36
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W3072334995
- Cited by
- 1,397
- References
- 2
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. https://app.cochat.ai/papers/10.1038/s41579-020-0420-1
- The paper
- Makabenta, J. M. V., Nabawy, A., Li, C.-H., Schmidt-Malan, S., Patel, R., & Rotello, V. M. (2021). Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-020-0420-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.